Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
Holders of 5% or more of KZR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Kezar Life Sciences, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Equal Talent Investments Ltd | 13D/A | 8.66%616.5K shares | – | Mar 3, 20251 filing | Mar 3, 2025 | SEC |
| Morningside Venture Investments Ltd | 13D/A | 8.45%616.5K shares | – | Feb 16, 20213 filings | Jan 16, 2025 | SEC |
| Avidity Partners Management LP | 13G/A | 6.90%502.6K shares | – | Jan 3, 20224 filings | Feb 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
51 Schedule 13D and 13G filings on Kezar Life Sciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 2, 20212:56 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Kezar Life Sciences, Inc. shares.
No Form 144 notices for Kezar Life Sciences, Inc. are on file.